share_log

中國中藥:根據《收購守則》規則22作出的交易披露

TRAD CHI MED: Disclosure of Dealings under Rule 22 of the Takeovers Code

HKEX ·  Aug 28 05:01

Summary by Moomoo AI

中國中藥控股有限公司(00570.HK)於2024年8月28日公布,其股份已透過協議安排進行私有化交易。根據香港《公司收購及合併守則》規則22,交易執行人員披露了相關證券交易資訊。CITIC Securities International Capital Management Limited於2024年8月27日清結了一筆涉及100,000股份的衍生工具合約,交易總金額為432,000美元,交易後該公司持股數量歸零。該交易由CITIC Securities International Capital Management Limited為自身帳戶所執行,並與要約人存在關聯。
中國中藥控股有限公司(00570.HK)於2024年8月28日公布,其股份已透過協議安排進行私有化交易。根據香港《公司收購及合併守則》規則22,交易執行人員披露了相關證券交易資訊。CITIC Securities International Capital Management Limited於2024年8月27日清結了一筆涉及100,000股份的衍生工具合約,交易總金額為432,000美元,交易後該公司持股數量歸零。該交易由CITIC Securities International Capital Management Limited為自身帳戶所執行,並與要約人存在關聯。
Trad chi med Holdings Limited (00570.HK) announced on August 28, 2024 that its shares have been privatized through an agreement arrangement. According to Rule 22 of the Hong Kong Code on Takeovers and Mergers, the transaction executor disclosed the relevant securities trading information. CITIC Securities International Capital Management Limited settled a derivative instrument contract involving 100,000 shares on August 27, 2024, with a total transaction amount of $432,000. After the transaction, the company's shareholding was reduced to zero. The transaction was executed by CITIC Securities International Capital Management Limited for its own account and was related to the offeror.
Trad chi med Holdings Limited (00570.HK) announced on August 28, 2024 that its shares have been privatized through an agreement arrangement. According to Rule 22 of the Hong Kong Code on Takeovers and Mergers, the transaction executor disclosed the relevant securities trading information. CITIC Securities International Capital Management Limited settled a derivative instrument contract involving 100,000 shares on August 27, 2024, with a total transaction amount of $432,000. After the transaction, the company's shareholding was reduced to zero. The transaction was executed by CITIC Securities International Capital Management Limited for its own account and was related to the offeror.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more